Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Heise

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonistsJonathan Grey, Brian Dyck, Martin W Rowbottom, et al.
Journal of Biomolecular Screening|September 24, 2011
Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready platesYichin Liu, Maureen H Beresini, Adam Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2006
Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonistsBrian Dyck, Liren Zhao, Junko Tamiya, et al.
The Journal of Biological Chemistry|April 23, 2002
The immune modulator FTY720 targets sphingosine 1-phosphate receptorsVolker Brinkmann, Michael D Davis, Christopher E Heise, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2007
Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonistsMingzhu Zhang, Junko Tamiya, Linh Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonistsCharles Q Huang, Tracy Baker, David Schwarz, et al.
The Journal of Biological Chemistry|May 9, 2000
Characterization of a novel sphingosine 1-phosphate receptor, Edg-8D S Im, C E Heise, N Ancellin, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2016
Synthesis and evaluation of a series of 4-azaindole-containing p21-activated kinase-1 inhibitorsWendy Lee, James J Crawford, Ignacio Aliagas, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2005
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonistChristopher E Heise, Anil Pahuja, Sarah C Hudson, et al.
Molecular and Cellular Endocrinology|September 22, 2006
Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 functionDavid A Schwarz, Molly M Allen, Robert E Petroski, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonistsJonathan Grey, Brian Dyck, Martin W Rowbottom, et al.
Journal of Biomolecular Screening|September 24, 2011
Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready platesYichin Liu, Maureen H Beresini, Adam Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2006
Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonistsBrian Dyck, Liren Zhao, Junko Tamiya, et al.
The Journal of Biological Chemistry|April 23, 2002
The immune modulator FTY720 targets sphingosine 1-phosphate receptorsVolker Brinkmann, Michael D Davis, Christopher E Heise, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2007
Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonistsMingzhu Zhang, Junko Tamiya, Linh Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonistsCharles Q Huang, Tracy Baker, David Schwarz, et al.
The Journal of Biological Chemistry|May 9, 2000
Characterization of a novel sphingosine 1-phosphate receptor, Edg-8D S Im, C E Heise, N Ancellin, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2016
Synthesis and evaluation of a series of 4-azaindole-containing p21-activated kinase-1 inhibitorsWendy Lee, James J Crawford, Ignacio Aliagas, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2005
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonistChristopher E Heise, Anil Pahuja, Sarah C Hudson, et al.
Molecular and Cellular Endocrinology|September 22, 2006
Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 functionDavid A Schwarz, Molly M Allen, Robert E Petroski, et al.
Pageof 8